Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiwen Zhang

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
Current Cancer Drug Targets|March 9, 2018
PrefaceRuiwen Zhang
Current Cancer Drug Targets|January 10, 2017
Preface: Scientific Premise and Rigors in Scientific Research, Peer Review, Editing and PublishingRuiwen Zhang
Current Cancer Drug Targets|January 30, 2025
Future Cancer Drug Discovery Is NowRuiwen Zhang
Current Cancer Drug Targets|January 24, 2019
PrefaceRuiwen Zhang
Current Cancer Drug Targets|November 12, 2025
PREFACERuiwen Zhang
Current Cancer Drug Targets|January 25, 2014
Editorial: looking forward to another successful yearRuiwen Zhang
The EMBO Journal|March 1, 2008
Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradationZhuo Zhang, Ruiwen Zhang
Methods in Molecular Medicine|November 1, 2002
Antisense oligonucleotides targeting RI alpha subunit of protein kinase A. In vitro and in vivo anti-tumor activity and pharmacokineticsRuiwen Zhang, Hui Wang
Methods in Molecular Medicine|April 25, 2003
Antisense oligonucleotide inhibitors of MDM2 oncogene expressionRuiwen Zhang, Hui Wang
Current Cancer Drug Targets|February 22, 2005
p53-independent activities of MDM2 and their relevance to cancer therapyZhuo Zhang, Ruiwen Zhang
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
Current Cancer Drug Targets|March 9, 2018
PrefaceRuiwen Zhang
Current Cancer Drug Targets|January 10, 2017
Preface: Scientific Premise and Rigors in Scientific Research, Peer Review, Editing and PublishingRuiwen Zhang
Current Cancer Drug Targets|January 30, 2025
Future Cancer Drug Discovery Is NowRuiwen Zhang
Current Cancer Drug Targets|January 24, 2019
PrefaceRuiwen Zhang
Current Cancer Drug Targets|November 12, 2025
PREFACERuiwen Zhang
Current Cancer Drug Targets|January 25, 2014
Editorial: looking forward to another successful yearRuiwen Zhang
The EMBO Journal|March 1, 2008
Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradationZhuo Zhang, Ruiwen Zhang
Methods in Molecular Medicine|November 1, 2002
Antisense oligonucleotides targeting RI alpha subunit of protein kinase A. In vitro and in vivo anti-tumor activity and pharmacokineticsRuiwen Zhang, Hui Wang
Methods in Molecular Medicine|April 25, 2003
Antisense oligonucleotide inhibitors of MDM2 oncogene expressionRuiwen Zhang, Hui Wang
Current Cancer Drug Targets|February 22, 2005
p53-independent activities of MDM2 and their relevance to cancer therapyZhuo Zhang, Ruiwen Zhang
Pageof 20